ALDEYRA THERAPEUTICS - REQUESTS FDA TRANSFER OF ADX-2191 IND REVIEW FOR PVRL TO DIVISION OF HEMATOLOGIC MALIGNANCIES 2 - SEC FILING

Reuters · 11/09 21:26

Please log in to view news